Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...
David Correa Allied Market Research + + 1 800-792-5285 email us here Visit us on social media: Facebook X LinkedIn YouTube ...
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...
Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...
SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...
An expert answers questions about physical therapy for psoriatic arthritis, from what to look for in a provider to what to ...
The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...
Staying active can help you manage psoriatic arthritis — as long as you do it right. Avoid these exercise mistakes to keep your joints moving.
A large European study finds that TNF inhibitors work differently across joints in psoriatic arthritis, with the shoulder and ...
Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, ...